miRNA pathwayMicroRNAs (miRNAs) are small (21-23 nucleotides in length) single stranded RNA molecules which are not translated into proteins but whose main function is to regulate gene expression. Almost all types of tumour have abnormal – usually reduced – miRNA expression, and scientists at Johns Hopkins Medical School, Nationwide Children’s Hospital, and Ohio State University have now shown that replacing missing miRNAs in mice with liver cancer can rapidly kill the tumour cells whilst leaving healthy cells untouched. The team found that hepatocellular carcinoma (HCC) cells had reduced levels of miR-26a, a miRNA that is normally expressed at high levels in a variety of tissues. In vitro, expression of miR-26a in liver cancer cells was shown to cause cell-cycle arrest associated with direct targeting of cyclins D2 and E2. Systemic administration of miR-26a to mice with HCC using an adeno-associated virus vector inhibited the proliferation of the cancer cells and protected the animals from disease progression. Normal liver cells were unaffected by the treatment. After three weeks, 8 out of 10 mice treated with the miRNA showed only small tumours or a complete absence of tumours, whereas 6 out of 8 sham-treated mice experienced aggressive disease progression.

The study shows that liver cancer can be successfully treated in an animal model of disease by replacing ‘missing’ miRNA using a delivery vector that is suitable for use in the clinic. Although more work is needed before the technique could be used in patients, it could provide an effective and safe treatment for human HCCs, which account for 80 – 90% of all liver cancers and generally have a poor prognosis. If suitable delivery systems can be developed, the technique could also be used to treat other diseases caused by ‘missing’ miRNA.

The study is published in the June 12th edition of Cell.

Related posts:

  1. Role for miRNA in Amyotrophic Lateral Sclerosis Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is one of the most common neuromuscular diseases worldwide and...
  2. Angiotensin 1-7 Inhibits Lung Cancer Tumour Growth in Mice The renin-angiotensin system was originally believed to be a relatively straightforward cascade involved primarily in controlling blood pressure and was...
  3. Decoy Receptor Reverses Cancer Cachexia, Improves Survival in Mice Debilitating muscle wasting or cachexia affects the majority of patients with advanced cancer but although the condition is believed to...
  4. Loss of microRNA in Malignant Mesothelioma MicroRNAs (miRNAs) are small (21-23 nucleotides), single-stranded RNA molecules that function as regulators of gene expression. The human genome encodes...
  5. Suppressing ROCK May Prevent Breast Cancer Metastases Nearly half of all patients treated for apparently localised breast cancer develop metastatic disease. Although there are treatment options that...

Related posts brought to you by Yet Another Related Posts Plugin.

This entry was posted on Tuesday, June 16th, 2009 at 8:30 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

2 Responses to “Replacement miRNA Treats Liver Cancer in Mice”
  1. [...] reported on miRNA involvement in cholesterol regulation, amyotrophic lateral sclerosis and liver cancer. Now a collaboration between Rosetta Genomics, NYU Langone Medical Center and Vanderbilt School of [...]

  2. Phil says:

    PCA3 is a RNA marker in urine for prostate cancer

  3.  
Leave a Reply